CEO @ Rovia Clinical Research Site Network (Private Equity Portfolio Company) | MBA | Eli Lilly | J&J

Stanford MBA; Duke B.S. Biology, Genetics Concentration, Economics Seasoned, healthcare operator of private equity portfolio companies with track record of delivering double digit MOIC (17x most recent) to shareholders. Specialized in building, scaling and transforming middle market businesses; deliver 50%+ growth. - Lead teams (up to 500 FTE) across HR, IT, Operations, BI, Sales, Marketing, PM, BD, and Integrations - Board of Directors and External Stakeholder Management - Hyper-Growth P&L Management: Organic, De Novo & M&A - Data-Driven, Operational Discipline - 20+ years in healthcare (multi-site healthcare services, healthcare tech, medical device, pharmacy services, hospital, digital health, DME, pharma, distribution, pet health) - Reliably produce results with agility and a high sense of urgency - Effectively top grade management and coach teams to unlock max potential - Excel in resource-constrained environments with best practice training from blue chip companies Qualifications include: ● P&L and Operations Management ● Leadership ● Strategy & Transformation ● Process improvement / Automation ● Sales & Marketing ● Business development and M&A ● Technology / Data science / Analytics ● Multi-Site Healthcare services, Value-Based Care, Pharmacy, Medical Devices, Pharma, Digital Health, Veterinary, Telehealth, DME, Home health, Distribution Email: pcasillas4@gmail.com